首页 > 最新文献

Alzheimer's & Dementia最新文献

英文 中文
An unsupervised learning approach for clustering joint trajectories of Alzheimer's disease biomarkers: An application to ADNI Data
IF 14 1区 医学 Q1 CLINICAL NEUROLOGY Pub Date : 2025-01-27 DOI: 10.1002/alz.14524
Teresa Filshtein Sönmez, Danielle J. Harvey, Laurel A. Beckett
Current models of Alzheimer's disease (AD) progression assume a common pattern and pathology, oversimplifying the heterogeneity of clinical AD.
{"title":"An unsupervised learning approach for clustering joint trajectories of Alzheimer's disease biomarkers: An application to ADNI Data","authors":"Teresa Filshtein Sönmez, Danielle J. Harvey, Laurel A. Beckett","doi":"10.1002/alz.14524","DOIUrl":"https://doi.org/10.1002/alz.14524","url":null,"abstract":"Current models of Alzheimer's disease (AD) progression assume a common pattern and pathology, oversimplifying the heterogeneity of clinical AD.","PeriodicalId":7471,"journal":{"name":"Alzheimer's & Dementia","volume":"23 1","pages":""},"PeriodicalIF":14.0,"publicationDate":"2025-01-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143044754","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Nutrition: A non-negligible factor in the pathogenesis and treatment of Alzheimer's disease 营养:阿尔茨海默病发病和治疗过程中不可忽视的因素
IF 14 1区 医学 Q1 CLINICAL NEUROLOGY Pub Date : 2025-01-27 DOI: 10.1002/alz.14547
Boye Wen, Xiaodong Han, Jin Gong, Pin Wang, Wenxian Sun, Chang Xu, Aidi Shan, Xin Wang, Heya Luan, Shaoqi Li, Ruina Li, Jinxuan Guo, Runqi Chen, Chuqiao Li, Yao Sun, Sirong Lv, Cuibai Wei
Alzheimer's disease (AD) is a degenerative disease characterized by progressive cognitive dysfunction. The strong link between nutrition and the occurrence and progression of AD pathology has been well documented. Poor nutritional status accelerates AD progress by potentially aggravating amyloid beta (Aβ) and tau deposition, exacerbating oxidative stress response, modulating the microbiota–gut–brain axis, and disrupting blood–brain barrier function. The advanced stage of AD tends to lead to malnutrition due to cognitive impairments, sensory dysfunctions, brain atrophy, and behavioral and psychological symptoms of dementia (BPSD). This, in turn, produces a vicious cycle between malnutrition and AD. This review discusses how nutritional factors and AD deteriorate each other from the early stage of AD to the terminal stages of AD, focusing on the potential of different levels of nutritional factors, ranging from micronutrients to diet patterns. This review provides novel insights into reducing the risk of AD, delaying its progression, and improving prognosis.
{"title":"Nutrition: A non-negligible factor in the pathogenesis and treatment of Alzheimer's disease","authors":"Boye Wen, Xiaodong Han, Jin Gong, Pin Wang, Wenxian Sun, Chang Xu, Aidi Shan, Xin Wang, Heya Luan, Shaoqi Li, Ruina Li, Jinxuan Guo, Runqi Chen, Chuqiao Li, Yao Sun, Sirong Lv, Cuibai Wei","doi":"10.1002/alz.14547","DOIUrl":"https://doi.org/10.1002/alz.14547","url":null,"abstract":"Alzheimer's disease (AD) is a degenerative disease characterized by progressive cognitive dysfunction. The strong link between nutrition and the occurrence and progression of AD pathology has been well documented. Poor nutritional status accelerates AD progress by potentially aggravating amyloid beta (Aβ) and tau deposition, exacerbating oxidative stress response, modulating the microbiota–gut–brain axis, and disrupting blood–brain barrier function. The advanced stage of AD tends to lead to malnutrition due to cognitive impairments, sensory dysfunctions, brain atrophy, and behavioral and psychological symptoms of dementia (BPSD). This, in turn, produces a vicious cycle between malnutrition and AD. This review discusses how nutritional factors and AD deteriorate each other from the early stage of AD to the terminal stages of AD, focusing on the potential of different levels of nutritional factors, ranging from micronutrients to diet patterns. This review provides novel insights into reducing the risk of AD, delaying its progression, and improving prognosis.","PeriodicalId":7471,"journal":{"name":"Alzheimer's & Dementia","volume":"34 1","pages":""},"PeriodicalIF":14.0,"publicationDate":"2025-01-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143044705","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Challenges in multimorbidity and cognitive function studies: A call for rigorous analysis and reporting
IF 14 1区 医学 Q1 CLINICAL NEUROLOGY Pub Date : 2025-01-27 DOI: 10.1002/alz.14391
Xiaozhi Chen, Zhiqiang Zhang

This letter is in response to “Multimorbidity measures associated with cognitive function among community-dwelling older Chinese adults” by Wang and colleagues.1

In their article, Wang et al. explored, using longitudinal survey data, the association of multimorbidity with cognitive function among older Chinese adults. We write to highlight key points for further exploration. First, exploratory factor analysis was used to examine the relationship among the 14 individual chronic conditions, but the Kaiser–Meyer–Olkin value of 0.67 can only indicate a mediocre pattern of correlations.2 Addtionally, more than half of the factor loading were below 0.5, which is considerded as a threshold value with practical significance.

As the authors note, most of these conditions were self-reported by participants except for components of sensory pattern; this may weaken the correlation between other patterns and cognitive function and likely explain the strongest association with cognitive function among sensory pattern both at baseline and the first follow-up; only sensory pattern showed similar results in both sexes compared with the total population may also be attributed to this. Similarly, participants with more chronic conditions were more likely to live in urban areas, possible explanation is that urban areas have relatively abundant medical resources compared to rural areas. These information biases caused by different disease detection rates may lead to a deviation from reality.3

Lack of death information is another issue. Although the study is still ongoing, the mortality data in a longitudinal study can be gradually updated during the follow-up period and analyzed based on existing data. Completely ignoring the impact of mortality may lead to bias in the risk assessment of cognitive decline, especially in the elderly population where mortality is a very common and significant competitive risk. Besides, the proportion of participants with the three multimorbidity patterns was not provided in the article, which directly affects the explanatory power of statistical analysis.4

Overall, this study provided interesting information on the multimorbidity measures and their association with cognitive performance in Chinese community-dwelling older adults. Nonetheless, imperfect exploratory factor analysis, information bias, and incomplete reporting impact its reliability and validity.

{"title":"Challenges in multimorbidity and cognitive function studies: A call for rigorous analysis and reporting","authors":"Xiaozhi Chen, Zhiqiang Zhang","doi":"10.1002/alz.14391","DOIUrl":"https://doi.org/10.1002/alz.14391","url":null,"abstract":"<p>This letter is in response to “Multimorbidity measures associated with cognitive function among community-dwelling older Chinese adults” by Wang and colleagues.<span><sup>1</sup></span></p>\u0000<p>In their article, Wang et al. explored, using longitudinal survey data, the association of multimorbidity with cognitive function among older Chinese adults. We write to highlight key points for further exploration. First, exploratory factor analysis was used to examine the relationship among the 14 individual chronic conditions, but the Kaiser–Meyer–Olkin value of 0.67 can only indicate a mediocre pattern of correlations.<span><sup>2</sup></span> Addtionally, more than half of the factor loading were below 0.5, which is considerded as a threshold value with practical significance.</p>\u0000<p>As the authors note, most of these conditions were self-reported by participants except for components of sensory pattern; this may weaken the correlation between other patterns and cognitive function and likely explain the strongest association with cognitive function among sensory pattern both at baseline and the first follow-up; only sensory pattern showed similar results in both sexes compared with the total population may also be attributed to this. Similarly, participants with more chronic conditions were more likely to live in urban areas, possible explanation is that urban areas have relatively abundant medical resources compared to rural areas. These information biases caused by different disease detection rates may lead to a deviation from reality.<span><sup>3</sup></span></p>\u0000<p>Lack of death information is another issue. Although the study is still ongoing, the mortality data in a longitudinal study can be gradually updated during the follow-up period and analyzed based on existing data. Completely ignoring the impact of mortality may lead to bias in the risk assessment of cognitive decline, especially in the elderly population where mortality is a very common and significant competitive risk. Besides, the proportion of participants with the three multimorbidity patterns was not provided in the article, which directly affects the explanatory power of statistical analysis.<span><sup>4</sup></span></p>\u0000<p>Overall, this study provided interesting information on the multimorbidity measures and their association with cognitive performance in Chinese community-dwelling older adults. Nonetheless, imperfect exploratory factor analysis, information bias, and incomplete reporting impact its reliability and validity.</p>","PeriodicalId":7471,"journal":{"name":"Alzheimer's & Dementia","volume":"36 1","pages":""},"PeriodicalIF":14.0,"publicationDate":"2025-01-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143044703","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Current practices by Alzheimer's Disease Research Centers to remunerate research participants
IF 14 1区 医学 Q1 CLINICAL NEUROLOGY Pub Date : 2025-01-27 DOI: 10.1002/alz.14542
Matthew Gabel, Semere Bekena, Mitch O'Meara, Andrea Denny, Erin D. Solomon, Krista L. Moulder, John C. Morris, Jessica Mozersky
Recent guidance from the National Alzheimer's Coordinating Center (NACC) recommends remuneration for all Alzheimer's disease (AD) research participants. Given AD research recruitment challenges, we assessed the remuneration practices at Alzheimer's Disease Research Centers (ADRCs).
{"title":"Current practices by Alzheimer's Disease Research Centers to remunerate research participants","authors":"Matthew Gabel, Semere Bekena, Mitch O'Meara, Andrea Denny, Erin D. Solomon, Krista L. Moulder, John C. Morris, Jessica Mozersky","doi":"10.1002/alz.14542","DOIUrl":"https://doi.org/10.1002/alz.14542","url":null,"abstract":"Recent guidance from the National Alzheimer's Coordinating Center (NACC) recommends remuneration for all Alzheimer's disease (AD) research participants. Given AD research recruitment challenges, we assessed the remuneration practices at Alzheimer's Disease Research Centers (ADRCs).","PeriodicalId":7471,"journal":{"name":"Alzheimer's & Dementia","volume":"84 1","pages":""},"PeriodicalIF":14.0,"publicationDate":"2025-01-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143044347","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Avoiding causal fraud in the evaluation of clinical benefits of treatments for Alzheimer's disease
IF 14 1区 医学 Q1 CLINICAL NEUROLOGY Pub Date : 2025-01-27 DOI: 10.1002/alz.14457
Kathy Y. Liu, Stephen Senn, Robert Howard
Recent regulatory approvals of three amyloid-lowering monoclonal antibody therapies for the treatment of Alzheimer's disease (AD) have triggered a polarizing debate in the field on the clinical meaningfulness of their reported effects. The question of how to define clinical meaningfulness for any treatment that has a modest effect size is important and will likely be subject to influence from interested stakeholders. We warn of claims of evaluating meaningful within-individual change from randomized parallel-group trials of AD treatments, sometimes purportedly assessed by a commonly recognized “responder” analysis approach, and explain why it is likely to mislead and should simply be avoided. The average between-group difference in score change is where the debate and research efforts should be focused to contextualize and evaluate the clinical meaningfulness of the true treatment effect. The statistical and communication principles we consider and would recommend are applicable to the evaluation of most interventions in medicine.
{"title":"Avoiding causal fraud in the evaluation of clinical benefits of treatments for Alzheimer's disease","authors":"Kathy Y. Liu, Stephen Senn, Robert Howard","doi":"10.1002/alz.14457","DOIUrl":"https://doi.org/10.1002/alz.14457","url":null,"abstract":"Recent regulatory approvals of three amyloid-lowering monoclonal antibody therapies for the treatment of Alzheimer's disease (AD) have triggered a polarizing debate in the field on the clinical meaningfulness of their reported effects. The question of how to define clinical meaningfulness for any treatment that has a modest effect size is important and will likely be subject to influence from interested stakeholders. We warn of claims of evaluating meaningful within-individual change from randomized parallel-group trials of AD treatments, sometimes purportedly assessed by a commonly recognized “responder” analysis approach, and explain why it is likely to mislead and should simply be avoided. The average between-group difference in score change is where the debate and research efforts should be focused to contextualize and evaluate the clinical meaningfulness of the true treatment effect. The statistical and communication principles we consider and would recommend are applicable to the evaluation of most interventions in medicine.","PeriodicalId":7471,"journal":{"name":"Alzheimer's & Dementia","volume":"22 1","pages":""},"PeriodicalIF":14.0,"publicationDate":"2025-01-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143044411","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Offspring education and cognitive health: A comparison between Hispanic and White older adults in the United States
IF 14 1区 医学 Q1 CLINICAL NEUROLOGY Pub Date : 2025-01-27 DOI: 10.1002/alz.14523
Erika Meza, Karla Renata Flores Romero, Isabel E. Allen, Hector M. González, M. Maria Glymour, Jacqueline M. Torres
We compared the relationship between offspring education and cognitive health outcomes among Hispanic and White adults.
{"title":"Offspring education and cognitive health: A comparison between Hispanic and White older adults in the United States","authors":"Erika Meza, Karla Renata Flores Romero, Isabel E. Allen, Hector M. González, M. Maria Glymour, Jacqueline M. Torres","doi":"10.1002/alz.14523","DOIUrl":"https://doi.org/10.1002/alz.14523","url":null,"abstract":"We compared the relationship between offspring education and cognitive health outcomes among Hispanic and White adults.","PeriodicalId":7471,"journal":{"name":"Alzheimer's & Dementia","volume":"48 1","pages":""},"PeriodicalIF":14.0,"publicationDate":"2025-01-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143044417","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A multi-cohort study of longitudinal and cross-sectional Alzheimer's disease biomarkers in cognitively unimpaired older adults
IF 14 1区 医学 Q1 CLINICAL NEUROLOGY Pub Date : 2025-01-27 DOI: 10.1002/alz.14492
Long Xie, Sandhitsu R. Das, Yue Li, Laura E. M. Wisse, Emily McGrew, Xueying Lyu, Michael DiCalogero, Ujashi Shah, Ademola Ilesanmi, Amanda E. Denning, Chris A. Brown, Jesse Cohen, Lasya Sreepada, Mengjin Dong, Niyousha Sadeghpour, Pulkit Khandelwal, Ranjit Ittyerah, Sadhana Ravikumar, Shokufeh Sadaghiani, Stanislau Hrybouski, Robin de Flores, Eli Gibson, Paul A. Yushkevich, David A. Wolk
The generalizability of neuroimaging and cognitive biomarkers in their sensitivity to detect preclinical Alzheimer's disease (AD) and power to predict progression in large, multisite cohorts remains unclear.
{"title":"A multi-cohort study of longitudinal and cross-sectional Alzheimer's disease biomarkers in cognitively unimpaired older adults","authors":"Long Xie, Sandhitsu R. Das, Yue Li, Laura E. M. Wisse, Emily McGrew, Xueying Lyu, Michael DiCalogero, Ujashi Shah, Ademola Ilesanmi, Amanda E. Denning, Chris A. Brown, Jesse Cohen, Lasya Sreepada, Mengjin Dong, Niyousha Sadeghpour, Pulkit Khandelwal, Ranjit Ittyerah, Sadhana Ravikumar, Shokufeh Sadaghiani, Stanislau Hrybouski, Robin de Flores, Eli Gibson, Paul A. Yushkevich, David A. Wolk","doi":"10.1002/alz.14492","DOIUrl":"https://doi.org/10.1002/alz.14492","url":null,"abstract":"The generalizability of neuroimaging and cognitive biomarkers in their sensitivity to detect preclinical Alzheimer's disease (AD) and power to predict progression in large, multisite cohorts remains unclear.","PeriodicalId":7471,"journal":{"name":"Alzheimer's & Dementia","volume":"34 1","pages":""},"PeriodicalIF":14.0,"publicationDate":"2025-01-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143044258","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Compositional brain scores capture Alzheimer's disease–specific structural brain patterns along the disease continuum
IF 14 1区 医学 Q1 CLINICAL NEUROLOGY Pub Date : 2025-01-27 DOI: 10.1002/alz.14490
Patricia Genius, M. Luz Calle, Blanca Rodríguez-Fernández, Carolina Minguillon, Raffaele Cacciaglia, Diego Garrido-Martin, Manel Esteller, Arcadi Navarro, Juan Domingo Gispert, Natalia Vilor-Tejedor,
Traditional multivariate methods for neuroimaging studies overlook the interdependent relationship between brain features. This study addresses this gap by analyzing relative brain volumetric patterns to capture how Alzheimer's disease (AD) and genetics influence brain structure along the disease continuum.
{"title":"Compositional brain scores capture Alzheimer's disease–specific structural brain patterns along the disease continuum","authors":"Patricia Genius, M. Luz Calle, Blanca Rodríguez-Fernández, Carolina Minguillon, Raffaele Cacciaglia, Diego Garrido-Martin, Manel Esteller, Arcadi Navarro, Juan Domingo Gispert, Natalia Vilor-Tejedor, ","doi":"10.1002/alz.14490","DOIUrl":"https://doi.org/10.1002/alz.14490","url":null,"abstract":"Traditional multivariate methods for neuroimaging studies overlook the interdependent relationship between brain features. This study addresses this gap by analyzing relative brain volumetric patterns to capture how Alzheimer's disease (AD) and genetics influence brain structure along the disease continuum.","PeriodicalId":7471,"journal":{"name":"Alzheimer's & Dementia","volume":"4 1","pages":""},"PeriodicalIF":14.0,"publicationDate":"2025-01-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143044338","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Accelerometer-measured physical activity timing with incident dementia
IF 14 1区 医学 Q1 CLINICAL NEUROLOGY Pub Date : 2025-01-27 DOI: 10.1002/alz.14452
Yuye Ning, Meilin Chen, Hao Yang, Jianping Jia
Moderate to vigorous physical activity (MVPA) is linked to lower dementia risk, though the optimal timing remains unclear.
{"title":"Accelerometer-measured physical activity timing with incident dementia","authors":"Yuye Ning, Meilin Chen, Hao Yang, Jianping Jia","doi":"10.1002/alz.14452","DOIUrl":"https://doi.org/10.1002/alz.14452","url":null,"abstract":"Moderate to vigorous physical activity (MVPA) is linked to lower dementia risk, though the optimal timing remains unclear.","PeriodicalId":7471,"journal":{"name":"Alzheimer's & Dementia","volume":"120 1","pages":""},"PeriodicalIF":14.0,"publicationDate":"2025-01-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143044413","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Natural language processing-based classification of early Alzheimer's disease from connected speech
IF 14 1区 医学 Q1 CLINICAL NEUROLOGY Pub Date : 2025-01-27 DOI: 10.1002/alz.14530
Helena Balabin, Bastiaan Tamm, Laure Spruyt, Nathalie Dusart, Ines Kabouche, Ella Eycken, Kevin Statz, Steffi De Meyer, Hugo Van Hamme, Patrick Dupont, Marie-Francine Moens, Rik Vandenberghe
The automated analysis of connected speech using natural language processing (NLP) emerges as a possible biomarker for Alzheimer's disease (AD). However, it remains unclear which types of connected speech are most sensitive and specific for the detection of AD.
{"title":"Natural language processing-based classification of early Alzheimer's disease from connected speech","authors":"Helena Balabin, Bastiaan Tamm, Laure Spruyt, Nathalie Dusart, Ines Kabouche, Ella Eycken, Kevin Statz, Steffi De Meyer, Hugo Van Hamme, Patrick Dupont, Marie-Francine Moens, Rik Vandenberghe","doi":"10.1002/alz.14530","DOIUrl":"https://doi.org/10.1002/alz.14530","url":null,"abstract":"The automated analysis of connected speech using natural language processing (NLP) emerges as a possible biomarker for Alzheimer's disease (AD). However, it remains unclear which types of connected speech are most sensitive and specific for the detection of AD.","PeriodicalId":7471,"journal":{"name":"Alzheimer's & Dementia","volume":"38 1","pages":""},"PeriodicalIF":14.0,"publicationDate":"2025-01-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143044414","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Alzheimer's & Dementia
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1